Lidocaine Numbing Cream for Clinical Use
Your comprehensive topical pain management solution
Time saving, cost effective solutions for skin “numbing”
Clinicians use lidocaine numbing cream to numb the skin for a variety of conditions and procedures. Topical lidocaine numbing cream desensitizes the skin by blocking neuronal transmission of pain signals to the brain. NeuroMed products are safe and effective when used as directed
NeuroMed lidocaine numbing cream products are light and creamy in texture. This leaves the skin feeling smooth and moisturized. They won’t leave a waxy, oily, gritty or flaky residue like other products. The proprietary skin penetrating formula is designed to reduce the amount of time for numbing to take effect from up to an hour for other numbing creams down to as little as 15 minutes for a full powerful effect.
Proprietary formula designed to speed onset time to as little as 15 minutes
Single-use, sanitary packets can reduce risk of cross contamination when compared to multi-use containers
Creamy, soft texture, does not leave, waxy, oily, gritty or flaky residue when applied or after removal
Very easy to apply and remove
Competitively priced in order to reduce clinical procurement cost
NeuroMed BLT Combination Package provides clinical options and flexibility unique to this product package not seen with any other competitive products
NeuroMed BLT Combination Package – 25 packet strips of each benzocaine 20%, lidocaine 4% and tetracaine 2%
NeuroMed7 Sanitary, Single-use packets and multi-use 2.2 ounce tubes (4% Lidocaine HCl)
Safe and Effective, Rapid Onset Topical Anesthetics (15 – 20 minute peak effect)
Features and Benefits
- Rapid onset of action
- Proven safe and effective both in clinical use settings as well as approved studies
- Easy to apply and remove
- Competitive cost
- Two-year shelf life from time of manufacture
- Third party tested for microbes and active ingredient concentration
- Supplied in both convenient, metered dosed, single-use, sanitary packets and multi-use tubes (tubes are for NeuroMed7 only)
- Easy access (no prescription required, designated OTC Monograph therapeutic anesthetic)
- FDA Compliant in accordance with the 21 CFR Monograph 348 OTC Topical Analgesics and Anesthetics
Sambria Pharmaceuticals supplies clinicians with NeuroMed 7 (4% lidocaine) and its NeuroMed BLT Variety Combination Package which includes: NeuroMed FA (benzocaine 20%), NeuroMed 7 (lidocaine 4%) and NeuroMed LA (tetracaine 2%). These products are also conveniently supplied in single-use, sanitary, metered dosed packets to mitigate the possibility of cross contamination. The pH of these products consistently presents between 6.8 – 7.2. All products are manufactured in accordance with FDA policy and in an FDA approved and monitored facility. Ingredients included to improve the rate of penetration include, ethoxydiglycol, MSM and propylene glycol.
QA tested three times throughout the manufacturing process to ensure the highest degree of quality prior to entry into the supply chain.
Contact Sambria™ Pharmaceuticals, llc via telephone (888.246.6601) or email
email@example.com or see your local medical device distributor to order products or for more information.
Important Safety Information:
Indication: NeuroMed Topical Anesthetic Creams indicated for use on intact skin in adults and children 2 years and older to provide topical local analgesia for superficial dermatological procedures. Contraindications: NeuroMed Topical Anesthetic Creams are contraindicated in patients with a known history of sensitivity to lidocaine, or local anesthetics of the amide or ester type and also contraindicated in patients with sensitivity to any component of the product. Warnings/Precautions: Methemoglobinemia has been associated with use of local anesthetics such as lidocaine. NeuroMed Topical Anesthetic Creams should be used with caution in patients with severe hepatic disease. When using NeuroMed Topical Anesthetics Creams in conjunction with one another or with other local anesthetic agents, the total dose of anesthetic should be considered due to the potential for additive systemic toxic effects. Contact with the eyes should be avoided.
This site intended for U.S. audiences only. Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.